Replies to post #32723 on MultiCell Technologies Inc (MCET)

[YN2]

I agree, this should easily be valued at a .01 with the patents they already hold and future game changing patents.

MCT-485 has demonstrated in in vitro models the ability to kill transformed liver cancer cells while not harming normal, non-transformed liver cells. "MCT-485 addresses the need to directly target liver cancer cells and not normal liver cells"

[Lucky_Charm$]

Unless they massively dilute, any dips will be eaten up.....I'll be waiting for the shake :)

MCET goes copper soon imo!